We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
FC
1251
Fayerweather Charles
$664K
DIP
1252
DT Investment Partners
Pennsylvania
$663K +$154K +2,750 +31%
LRPA
1253
L. Roy Papp & Associates
Arizona
$660K
BOS
1254
Bingham Osborn & Scarborough
California
$657K +$253K +4,503 +63%
AB
1255
AT Bancorp
Iowa
$655K -$78.1K -1,390 -11%
BIM
1256
Baldwin Investment Management
Pennsylvania
$655K
SFA
1257
Sequoia Financial Advisors
Ohio
$654K -$10.8K -192 -2%
SC
1258
Savant Capital
Illinois
$653K +$192K +3,424 +42%
TBA
1259
Train Babcock Advisors
New York
$647K
BBI
1260
Baxter Bros Inc
Connecticut
$647K +$10.4K +185 +2%
CB
1261
Cooke & Bieler
Pennsylvania
$646K
HHGA
1262
Halbert Hargrove Global Advisors
California
$646K +$55.6K +990 +9%
SKK
1263
Shepherd Kaplan Krochuk
Massachusetts
$645K +$14.2K +252 +2%
DBT
1264
Dubuque Bank & Trust
Iowa
$643K +$393 +7 +0.1%
WP
1265
WMS Partners
Maryland
$641K +$1.35K +24 +0.2%
VAM
1266
Visium Asset Management
New York
$634K -$14.6M -259,568 -96%
FWM
1267
Focused Wealth Management
New York
$631K -$449 -8 -0.1%
TCB
1268
Texas Capital Bancshares
Texas
$629K -$111K -1,982 -15%
SC
1269
Schulhoff & Co
Ohio
$629K
IUAM
1270
Itau USA Asset Management
New York
$622K
VIM
1271
Veritas Investment Management
United Kingdom
$622K
SAMC
1272
Shinko Asset Management Company
Japan
$620K -$45.4K -808 -7%
WPP
1273
Whalerock Point Partners
Rhode Island
$619K -$74.7K -1,330 -11%
PFPT
1274
Pinnacle Financial Partners (Tennessee)
Tennessee
$618K -$4.16K -74 -0.7%
NA
1275
NSB Advisors
New York
$614K

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.